Related Experiment Video
Updated: Jan 12, 2026

05:18
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
Published on: October 6, 2023
1.8K
Beyond Standard Radiotherapy: an AI-Driven Framework for Personalized Radiotherapy with a Four-Step Classification in
Yongxin Guo1,2, Eric O Aboagye1, Dorothy M Gujral3
1Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, W12 0NN, United Kingdom.
Current Oncology Reports
|November 1, 2025
Summary
Artificial intelligence (AI) models show promise in personalizing radiotherapy for head and neck cancer (HNC). Radiomics analysis can predict outcomes and guide risk-adapted treatments, improving patient care.
Area of Science:
- Oncology
- Medical Imaging
- Artificial Intelligence
Background:
- Radiotherapy (RT) is a primary treatment for head and neck cancer (HNC).
- Personalizing RT has faced challenges, with variable results across treatment stages.
Purpose of the Study:
- To evaluate the potential of AI-driven models for personalized radiotherapy strategies in HNC.
- To assess how AI can bridge existing gaps in personalized RT.
Main Methods:
- Review of radiomics and AI-driven imaging analytics approaches.
- Analysis of AI-driven multimodal and multitemporal imaging models.
- Examination of a proposed four-step AI-driven RT framework.
Main Results:
- Radiomics offers quantitative features for predicting survival, treatment response, and toxicity.
- Radiomics models show high predictive efficacy (C-index/AUC > 0.70).
- AI models can stratify patients and guide risk-adapted radiotherapy.
Conclusions:
- AI-driven radiomics holds significant potential for personalized radiotherapy in HNC.
- AI models can enhance treatment stratification and risk adaptation.
- A standardized AI framework could facilitate future clinical trials and evidence generation.
Related Concept Videos
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K

